The Dual Syk/JAK Inhibitor Cerdulatinib Antagonizes B-cell Receptor and Microenvironmental Signaling in Chronic Lymphocytic LeukemiaMatthew D. Blunt, Andrew J. Steele|Clinical Cancer Research|2016Cited by 64
Selinexor Enhances NK Cell Activation Against Malignant B Cells via Downregulation of HLA-EJack G. Fisher, Matthew D. Blunt|Frontiers in Oncology|2021Cited by 22